Please assess the completion status of the following clinical trial:

Trial Title: Treating Acutely Agitated Patients With Asenapine Sublingual Tablets

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients will be between the ages of 18 and 65~* Be acutely agitated as determined by a total score of ≧ 14 on the PANSS-EC and at least one individual item score of ≧ 4~* Patients must have the capacity to provide informed consent, and such consent will be obtained prior to participation~Exclusion Criteria:~* Patient is knowingly pregnant~* Patient is less than 18 or greater than 65 years old~* Patient had a past adverse or allergic response to Asenapine

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Asenapine (Type: EXPERIMENTAL): This group received 10mg asenapine sl x 1 dose
- Placebo (Type: PLACEBO_COMPARATOR): This group received placebo sl x 1 dose

Based on this trial design, predict the completion outcome and termination type (if applicable).